Search for other papers by Noha Mukhtar in
Google Scholar
PubMed
Search for other papers by Hadeel Aljamei in
Google Scholar
PubMed
Search for other papers by Abeer Aljomaiah in
Google Scholar
PubMed
Search for other papers by Yosra Moria in
Google Scholar
PubMed
Search for other papers by Ali S. Alzahrani in
Google Scholar
PubMed
risk of recurrence and mortality [ 8 ]. Tumors that are low risk are usually treated more conservatively with lobectomy and do not routinely receive radioactive iodine (I-131) while high-risk tumors are treated more proactively with total or near
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Search for other papers by Daniele Ceruti in
Google Scholar
PubMed
Search for other papers by Simone De Leo in
Google Scholar
PubMed
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Search for other papers by Grzegorz Bilo in
Google Scholar
PubMed
Search for other papers by Matteo Trevisan in
Google Scholar
PubMed
Search for other papers by Noemi Giancola in
Google Scholar
PubMed
Search for other papers by Claudia Moneta in
Google Scholar
PubMed
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Search for other papers by Gianfranco Parati in
Google Scholar
PubMed
Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
-up of advanced radioiodine-refractory thyroid cancer . European Thyroid Journal 2019 8 227 – 245 . ( https://doi.org/10.1159/000502229 ) 2 Dadu R & Cabanillas ME . Optimizing therapy for radioactive iodine-refractory differentiated thyroid
Search for other papers by Andries H Groen in
Google Scholar
PubMed
Search for other papers by Deborah van Dijk in
Google Scholar
PubMed
Search for other papers by Wim Sluiter in
Google Scholar
PubMed
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Hendrik P Bijl in
Google Scholar
PubMed
Search for other papers by John T M Plukker in
Google Scholar
PubMed
by radioactive iodine ( 131 I) and thyroid-stimulating hormone suppression therapy ( 2 , 3 , 4 ). However, 15–33% of DTC patients have a primary iodine refractory-differentiated thyroid cancer (IR-DTC) or develop IR-DTC after several sessions of
Search for other papers by Abdul Rehman Syed in
Google Scholar
PubMed
Search for other papers by Aakash Gorana in
Google Scholar
PubMed
Search for other papers by Erik Nohr in
Google Scholar
PubMed
Search for other papers by Xiaoli-Kat Yuan in
Google Scholar
PubMed
Search for other papers by Parthiv Amin MASc in
Google Scholar
PubMed
Search for other papers by Sana Ghaznavi in
Google Scholar
PubMed
Search for other papers by Debbie Lamb in
Google Scholar
PubMed
Search for other papers by John McIntyre in
Google Scholar
PubMed
Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
– 1035 . ( https://doi.org/10.1158/1078-0432.CCR-14-2915 ) 8 Groussin L Clerc J & Huillard O . Larotrectinib-enhanced radioactive iodine uptake in advanced thyroid cancer . New England Journal of Medicine 2020 383 1686 – 1687 . ( https
Search for other papers by E.N. Klein Hesselink in
Google Scholar
PubMed
Search for other papers by T.P. Links in
Google Scholar
PubMed
, Goellner JR, Morris JC, Heufelder AE: Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. J Clin Endocrinol Metab 1999;84:4178-4184. 10.1210/jcem.84.11.6117 10566669 8 Mandel SJ, Mandel L: Radioactive iodine and the
Search for other papers by Nicholas S. Andresen in
Google Scholar
PubMed
Search for other papers by John M. Buatti in
Google Scholar
PubMed
Search for other papers by Hamed H. Tewfik in
Google Scholar
PubMed
Search for other papers by Nitin A. Pagedar in
Google Scholar
PubMed
Search for other papers by Carryn M. Anderson in
Google Scholar
PubMed
Search for other papers by John M. Watkins in
Google Scholar
PubMed
systematic review and meta-analysis of radioactive iodine remnant ablation for well-differentiated thyroid cancer: J Clin Endocrinol Metab 2002;89: 3668–3676. 10.1210/jc.2003-031167 15292285 3 Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE
Search for other papers by Rosa M. García-Moreno in
Google Scholar
PubMed
Search for other papers by Cristina Escabias in
Google Scholar
PubMed
Search for other papers by Cristina Utrilla in
Google Scholar
PubMed
Search for other papers by Elena Ruiz-Bravo in
Google Scholar
PubMed
Search for other papers by Margarita Sánchez in
Google Scholar
PubMed
Search for other papers by Beatriz Lecumberri in
Google Scholar
PubMed
radioactive iodine [ 2 ]. While, globally, the most common metastatic sites are cervical lymph nodes, distant metastases typically involve lungs, bones, and, less frequently, the brain [ 3 ]. Only in rare cases, patients may present metastases in unusual
Search for other papers by Andrew J Bauer in
Google Scholar
PubMed
Search for other papers by Jonathan D Wasserman in
Google Scholar
PubMed
Search for other papers by Steven G Waguespack in
Google Scholar
PubMed
human thyroid-stimulating hormone for radioactive iodine (RAI) imaging and therapy, reducing the minimum time on a low-iodine diet to 4 days prior to 131 I, and modifying the recommendation for lifelong surveillance from the 2015 ATA Pediatric
Search for other papers by Chantal Daumerie in
Google Scholar
PubMed
Search for other papers by Jacques Orgiazzi in
Google Scholar
PubMed
, three options may be considered: a second course of antithyroid drug, continuation of the antithyroid drug at low dose if appropriate, or radical treatment – either total thyroidectomy or radioactive iodine. Another important observation is that GD, and
Search for other papers by Kathrin A. Schmohl in
Google Scholar
PubMed
Search for other papers by Andrea M. Müller in
Google Scholar
PubMed
Search for other papers by Nathalie Schwenk in
Google Scholar
PubMed
Search for other papers by Kerstin Knoop in
Google Scholar
PubMed
Search for other papers by Eddy Rijntjes in
Google Scholar
PubMed
Search for other papers by Josef Köhrle in
Google Scholar
PubMed
Search for other papers by Heike Heuer in
Google Scholar
PubMed
Search for other papers by Peter Bartenstein in
Google Scholar
PubMed
Search for other papers by Burkhard Göke in
Google Scholar
PubMed
Search for other papers by Peter J. Nelson in
Google Scholar
PubMed
Search for other papers by Christine Spitzweg in
Google Scholar
PubMed
tissues in mice. Proc Soc Exp Biol Med 1947;66:212-213. 10.3181/00379727-66-16040P 20270727 4 Gorbman A: Functional and structural changes consequent to high dosages of radioactive iodine. J Clin Endocrinol Metab 1950;10:1177-1191. 10.1210/jcem-10